Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02755545 · ClinicalTrials.gov registry record · Phase 4
A Clinical Trial to Evaluate the Efficacy of Two Acne Treatments
A Phase 4 study of Acne, sponsored by Galderma R&D.
- Completed
- Registry status
- Phase 4
- Development phase
- 127
- Enrollment target
- 1
- Study location
NCT02755545 is a Phase 4 study of Acne that has completed, run by Galderma R&D. The registered enrollment target is 127 participants, roughly in line with the 138-participant average among 26 other Acne trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT02755545, a Phase 4 study of Acne, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 127 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the efficacy of 2 acne treatments for 24 weeks of use in adult men and women with mild to moderate facial acne, at least 5 inflammatory lesions, and at least 10 - 100 non-inflammatory lesions.
Conditions Studied
Interventions
- DRUG Product A
- DRUG Product B
Study Locations (1)
Texas
- Stephens & Associates, Inc. Texas Research Center - Richardson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2016-05-01 |
| Est. Completion | 2017-04-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02755545
The ClinicalTrials.gov registry entry for NCT02755545 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 127 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 138-participant average among 26 other Acne trials with a reported enrollment target. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acne appearing as the primary indexed condition, and to 2 interventions - of which Product A is the first listed.
NCT02755545 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02755545 about?
NCT02755545 is a clinical study titled "A Clinical Trial to Evaluate the Efficacy of Two Acne Treatments". The purpose of this study is to evaluate the efficacy of 2 acne treatments for 24 weeks of use in adult men and women with mild to moderate facial acne, at least 5 inflammatory lesions, and at least 10 - 100 non-inflammatory lesions.
What is the current status of trial NCT02755545?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 127 participants. The study started on 2016-05-01. Estimated completion is 2017-04-04.
What conditions does trial NCT02755545 study?
This clinical trial studies the following conditions: Acne.
What interventions are being tested in trial NCT02755545?
The interventions under investigation include: Product A (DRUG), Product B (DRUG).
Who is sponsoring clinical trial NCT02755545?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02755545 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comparative Effectiveness Study of Spironolactone Versus Doxycycline for Acne
ACTIVE NOT RECRUITING · Phase 4
-
Analysis of Adherence & Associated Factors in Teenagers Undergoing Treatment of Acne Vulgaris With Differin® Gel 0.1%
COMPLETED · Phase 4
-
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
COMPLETED · Phase 4
-
Profiling the Skin Microbiome in Response to Altreno in Acne Patients
COMPLETED · Phase 4
-
Administration of Oral Extended Release Minocycline for Assessment of Skin and Plasma Concentrations of Minocycline
COMPLETED · Phase 4
-
Comparison Study of Topical Acne Regimens
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.